Search

Your search keyword '"Schistosomiasis enzymology"' showing total 129 results

Search Constraints

Start Over You searched for: Descriptor "Schistosomiasis enzymology" Remove constraint Descriptor: "Schistosomiasis enzymology"
129 results on '"Schistosomiasis enzymology"'

Search Results

1. Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis.

2. JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation.

Catalog

Books, media, physical & digital resources

3. Increased expression of NTPDases 2 and 3 in mesenteric endothelial cells during schistosomiasis favors leukocyte adhesion through P2Y1 receptors.

4. [Observation on serum γ-glutamyl transpeptidase levels of patients with subclinical schistosomiasis before and after pathogen treatment].

5. Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges.

6. [Clinical efficacy of sodium tanshinone IIA sulfonate in treatment of advanced schistosomiasis].

7. Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

8. [Relationship between advanced schistosomiasis and HBV infection].

9. Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?

10. Increased endothelial cell-leukocyte interaction in murine schistosomiasis: possible priming of endothelial cells by the disease.

11. Succinate cytochrome c reductase in schistosomiasis: in vitro inhibition by some schistosomicidal drugs.

12. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.

13. Protein tyrosine kinases as new potential targets against human schistosomiasis.

14. CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis.

15. In vitro effect of schistosomicidal drugs on hepatic arylsulfatase B from the schistosoma-infected mouse.

16. Development of the rapid and simple elisa (whole blood-ELISA) using coconut water-tween as a wash solution for whole blood sample from Schistosoma japonicum-infected rabbit and human.

17. Activity of some hepatic enzymes in schistosomiasis and concomitant alteration of arylsulfatase B.

18. Detection of inducible nitric oxide synthase in Schistosoma japonicum and S. mansoni.

19. Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients.

20. Nitric oxide synthase immunoreactivity in human bladder carcinoma.

21. Changes in the expression of cytochrome P450 2E1 and the activity of carcinogen-metabolizing enzymes in Schistosoma haematobium-infected human bladder tissues.

22. Inhibition of nitric oxide synthase activity reduces liver injury in murine schistosomiasis.

23. Proteolytic degradation of host hemoglobin by schistosomes.

24. Antibody to hepatitis C virus in patients with chronic schistosomiasis.

25. Serum trypsin in hepatosplenic schistosomiasis in the Sudan.

26. The serum alkaline phosphatase in schistosomiasis.

27. Granuloma collagenase and EDTA-sensitive neutral protease production in hepatic murine schistosomiasis.

31. Angiotensin-converting enzyme and other enzymes in livers of mice with experimental schistosomiasis.

32. Production of angiotensin I converting enzyme by liver granuloma macrophages of Schistosoma mansoni infected mice.

33. Enzyme immunoassays for parasitic diseases.

34. Lipid pattern in Bilharzial hepatic fiprosis.

35. Biochemical studies on beta-glucuronidase enzyme in liver and spleen homogenates of normal and Schistosoma mansoni infected mice treated with hycanthone.

37. Biochemical studies on beta-glucuronidase in the urinary bladder of normal and Schistosoma mansoni infected mice treated with hycanthone.

38. Serum and urinary ribonuclease in children with schistosomal hepatic fibrosis.

39. Role of lipoxygenase products in murine pulmonary granuloma formation.

40. beta-Glucuronidase in schistosomal intestinal polypi of the colon.

41. Arylsulfatases in bilharziasis.

43. Alteration of granuloma angiotensin I-converting enzyme activity by regulatory T lymphocytes in murine schistosomiasis.

44. beta-Glucuronidase activity in liver and spleen homogenates of mice experimentally infected with Schistosoma mansoni.

45. Detection of granuloma-associated plasminogen activator in experimental murine schistosomiasis.

46. The effect of splenectomy on plasma phosphatidylcholine--cholesterol acyltransferase activity and blood lipids in human schistosomiasis mansoni [proceedings].

48. Effect of oxamniquine on liver, spleen, kidney and bladder B-glucuronidase in normal and Schistosoma mansoni infected mice.

50. Urinary leucine aminopeptidase in bilharziasis.